Evodiamine synergizes with doxorubicin in the treatment of chemoresistant human breast cancer without inhibiting P-glycoprotein
about
Stachydrine hydrochloride inhibits proliferation and induces apoptosis of breast cancer cells via inhibition of Akt and ERK pathwaysPseudopyronine B: A Potent Antimicrobial and Anticancer Molecule Isolated from a Pseudomonas mosselii.Anti-proliferative activity and cell cycle arrest induced by evodiamine on paclitaxel-sensitive and -resistant human ovarian cancer cellsSilencing Op18/stathmin by RNA Interference Promotes the Sensitivity of Nasopharyngeal Carcinoma Cells to Taxol and High-Grade Differentiation of Xenografted Tumours in Nude Mice.Evodiamine induces apoptosis and enhances apoptotic effects of erlotinib in wild-type EGFR NSCLC cells via S6K1-mediated Mcl-1 inhibition.Evodiamine and Its Role in Chronic Diseases.Polymeric mixed micelles loaded mitoxantrone for overcoming multidrug resistance in breast cancer via photodynamic therapy.Schisandrin B reverses doxorubicin resistance through inhibiting P-glycoprotein and promoting proteasome-mediated degradation of survivin.Zhi Zhen Fang formula reverses Hedgehog pathway mediated multidrug resistance in colorectal cancer.Anti-cancer Activity of Natural and Synthetic Capsaicin Analogs.Evodiamine Prevents Glioma Growth, Induces Glioblastoma Cell Apoptosis and Cell Cycle Arrest through JNK Activation.Epigallocatechin-3-gallate potentiates the effect of curcumin in inducing growth inhibition and apoptosis of resistant breast cancer cells.Evodiamine Suppresses ABCG2 Mediated Drug Resistance by Inhibiting p50/p65 NF-κB Pathway in Colorectal Cancer.Anti-cancer effects of Rhizoma Curcumae against doxorubicin-resistant breast cancer cellsEvodiamine Induces Apoptosis, G2/M Cell Cycle Arrest, and Inhibition of Cell Migration and Invasion in Human Osteosarcoma Cells via Raf/MEK/ERK Signalling Pathway
P2860
Q33623156-0FF97555-3CB8-4C3F-AE51-E9ACDD4669D5Q36129650-01C87191-9247-4A6F-90A8-9853A7490F78Q36265840-441ECB40-93EA-4749-ACB5-830C4B1FB5FDQ38764993-011E050E-34DE-4EF7-B237-C8501FC3F7EFQ38804415-2C5ED6D1-965E-4670-9B0B-0E9E4B997928Q38807050-E9024032-8C40-44C6-8E0E-599AD15F7687Q41354610-9DDAC7C3-C790-41F0-9372-F8E6E48EC119Q41489534-7BFCF7D1-6934-4708-84AF-DECBA21A65CBQ47138392-9E874A28-8040-4E39-BA40-C4631607153AQ47778782-98933770-83D3-437E-B9B4-B08A20A784CAQ50996270-1B91FDE5-FA8E-440D-BA27-ED2355350B4AQ51051788-61C95BB9-6DD5-4A1C-B464-3E81B5912B07Q53275441-460851D1-F1A1-42C8-97D5-7EC5C440BB51Q57166874-92D2E726-9488-442E-B124-C73150A7F74CQ58712167-D3C84AE1-A611-4BBA-BFF3-B3BF5BFD4AB1
P2860
Evodiamine synergizes with doxorubicin in the treatment of chemoresistant human breast cancer without inhibiting P-glycoprotein
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Evodiamine synergizes with dox ...... hout inhibiting P-glycoprotein
@ast
Evodiamine synergizes with dox ...... hout inhibiting P-glycoprotein
@en
Evodiamine synergizes with dox ...... hout inhibiting P-glycoprotein
@nl
type
label
Evodiamine synergizes with dox ...... hout inhibiting P-glycoprotein
@ast
Evodiamine synergizes with dox ...... hout inhibiting P-glycoprotein
@en
Evodiamine synergizes with dox ...... hout inhibiting P-glycoprotein
@nl
prefLabel
Evodiamine synergizes with dox ...... hout inhibiting P-glycoprotein
@ast
Evodiamine synergizes with dox ...... hout inhibiting P-glycoprotein
@en
Evodiamine synergizes with dox ...... hout inhibiting P-glycoprotein
@nl
P2093
P2860
P3181
P1433
P1476
Evodiamine synergizes with dox ...... hout inhibiting P-glycoprotein
@en
P2093
Meiwan Chen
Shengpeng Wang
Yitao Wang
Zhangfeng Zhong
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0097512
P407
P577
2014-01-01T00:00:00Z